Anatara Lifesciences Ltd (ASX:ANR) Chairman's Address to Shareholders
Anatara Lifesciences Ltd (ASX:ANR) provides the Chairman's address to shareholders.
Anatara Lifesciences Ltd (ASX:ANR) provides the Chairman's address to shareholders.
Anatara Lifesciences (ASX:ANR) CSO, Dr Tracey Mynott, was recently invited to present at the Translational Research Institute's Science Business Inspiration Series. The series was launched with Session 1 "The whole journey: from idea to reality".
Regeneus Ltd (ASX:RGS) provides the Company's Chairman's address to shareholders and CEO presentation at 2017 Annual General Meeting.
Regeneus Ltd (ASX:RGS) provides the Company's Presentation on Japan First Strategy at Ord Minnett.
During the September Quarter 2017, Queensland Bauxite Limited (ASX:QBL) continued to press to progress the development of its flagship South Johnstone DSO bauxite project in northern Queensland, with the Company aiming to generate positive net cash flows in the short term through the commencement of DSO bauxite production and shipping.
The Board of Queensland Bauxite (ASX:QBL) is most excited to announce that via its subsidiary Medical Cannabis Ltd, the initial sample range of hemp products under the name Vitahemp, will be ready for introduction to the Australian market in November 2017. Hemp foods are an extremely nutritious form of food product made from low THC Cannabis.
Nanollose Limited (ASX:NC6), an innovative Plant-Free Cellulose technology company, is pleased to announce that it will commence trading on the Australian Stock Exchange under ASX code NC6 at 1:00pm ADST today, following the successful completion of its Initial Public Offering.